"Health systems face immense pressure daily and cannot afford to utilize technologies that are not effective from the outset," says Michael Braginsky, CTO and co-founder, Aidoc. "The aiOS™ is designed precisely for the purpose of ensuring that cutting-edge technologies can be leveraged with minimal time from IT teams within a hospital enabling easy deployment. The goal is that with the combined power of Aidoc's aiOS™ and our foundation model we will deliver a potent one-two punch intended to provide the optimal solution for scaling AI in healthcare."

Aidoc's commitment to innovation and healthcare leadership is reinforced by this investment. Already processing millions of patient scans each month, the company aims to harness this technology to new avenues such as clinically accurate assessment of future clinical outcomes, simulation of future follow-up exams, flexible extraction of characteristics for biomarker research, complete normalization of medical data, and more.

About Aidoc
Aidoc is a pioneering force in clinical AI. We focus on aiding and empowering healthcare teams to optimize patient treatment, which results in improved economic value and clinical outcomes. Our clinically proven AI solutions eliminate silos, increase efficiencies, and improve outcomes by delivering critical information when and where care teams need it, leading to immediate collective action. Built on Aidoc's proprietary aiOS™, we analyze and aggregate medical data to enable care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Used in more than 1,000 medical centers worldwide, Aidoc has the most FDA clearances (13) in clinical AI, and its AI-based solutions cover 75 percent of patient populations, enabling physicians to make informed decisions based on real-time data. Aidoc AI is always on, running in the background to change the foreground. Visit Aidoc.com to see how we are connecting all points of care with always on AI.

Back to HCB News

Artificial Intelligence Homepage